Published in JAMA on May 26, 1999
Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol (2005) 2.73
Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev (2010) 1.89
Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study. BMJ (2010) 1.58
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag (2010) 1.16
Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Heart (2005) 1.05
Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis (2007) 1.04
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS One (2012) 0.89
Ivabradine: the evidence of its therapeutic impact in angina. Core Evid (2008) 0.87
Management standards for stable coronary artery disease in India. Indian Heart J (2016) 0.86
A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: the ESP-CAD trial protocol [NCT00175240]. Implement Sci (2006) 0.83
Angina treatments and prevention of cardiac events: an appraisal of the evidence. Eur Heart J Suppl (2015) 0.78
Treatment of stable angina. Heart (2007) 0.78
Drug efficacy in treating stable angina pectoris: a protocol for network meta-analysis of randomised controlled trials. BMJ Open (2014) 0.78
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol (2015) 0.77
Coronary artery disease: part 2. Treatment. West J Med (2001) 0.76
Long term medical treatment of stable coronary disease. Heart (2007) 0.76
Therapy for stable angina in women. P T (2012) 0.75
Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy. Neth Heart J (2002) 0.75
Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. Eur Heart J Qual Care Clin Outcomes (2016) 0.75
Anti-anginal and anti-ischemic effects of late sodium current inhibition. Cardiovasc Drugs Ther (2013) 0.75
Meta-analysis of acupuncture therapy for the treatment of stable angina pectoris. Int J Clin Exp Med (2015) 0.75
Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2005) 0.75
Sex-specific factors in microvascular angina. Can J Cardiol (2014) 0.75
Stable ischemic heart disease in women: current perspectives. Int J Womens Health (2017) 0.75
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
A working guide to boosted regression trees. J Anim Ecol (2008) 10.90
High throughput fingerprint analysis of large-insert clones. Genome Res (1997) 6.91
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J Virol (1982) 6.56
Dilute (d) coat colour mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome. Nature (1981) 4.77
Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ) (2001) 4.60
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation (1993) 3.54
Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol (2001) 3.39
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab (1999) 3.03
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg (1992) 2.72
Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med (1996) 2.55
Tetanus and diphtheria immunity in urban Minnesota adults. JAMA (1979) 2.53
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49
The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA (1995) 2.38
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA (1989) 2.33
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Characteristics of Vibrio parahaemolyticus O3:K6 from Asia. Appl Environ Microbiol (2000) 2.09
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol (1990) 2.06
Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med (1987) 1.98
Overestimation of clinical diagnostic performance caused by low necropsy rates. Qual Saf Health Care (2005) 1.82
Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Arch Intern Med (1994) 1.80
The autopsy as an outcome and performance measure. Evid Rep Technol Assess (Summ) (2002) 1.71
Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol (1982) 1.65
Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci U S A (1995) 1.63
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation (1990) 1.61
Association of the lethal yellow (Ay) coat color mutation with an ecotropic murine leukemia virus genome. Proc Natl Acad Sci U S A (1983) 1.60
The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol (2001) 1.58
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57
Tying clinical research to patient care by use of an observational database. Stat Med (1985) 1.56
Patient preferences in coronary revascularization. Am Heart J (1999) 1.53
Geographic origin of the Y chromosomes in "old" inbred strains of mice. Mamm Genome (1992) 1.53
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail (1995) 1.52
Incorporation of L-methionine-methyl-14C into gentamicins. J Antibiot (Tokyo) (1973) 1.49
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
Patient preferences and clinical guidelines. JAMA (1995) 1.48
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am J Cardiol (1991) 1.48
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol (2001) 1.46
Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol (1995) 1.42
The mouse Y* chromosome involves a complex rearrangement, including interstitial positioning of the pseudoautosomal region. Cytogenet Cell Genet (1991) 1.39
Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med (2001) 1.39
Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Am Heart J (2000) 1.38
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect (2000) 1.35
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene (2009) 1.34
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer (1997) 1.32
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol (1986) 1.30
Sex-determining genes on mouse autosomes identified by linkage analysis of C57BL/6J-YPOS sex reversal. Nat Genet (1996) 1.27
Localizing coronary artery obstructions with the exercise treadmill test. Ann Intern Med (1987) 1.24
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest (1977) 1.24
Evaluating quality of care for patients with heart failure. Circulation (2000) 1.21
Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci U S A (1999) 1.20
The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med (1978) 1.18
Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med (1997) 1.18
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation. Am J Physiol (1975) 1.16
Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med (1989) 1.16
Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology (2002) 1.14
Estimating the likelihood of severe coronary artery disease. Am J Med (1991) 1.14
Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain (2001) 1.13
Distributed decision support using a web-based interface: prevention of sudden cardiac death. Med Decis Making (1999) 1.12
Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med (1997) 1.11
Y chromosome evolution in the subgenus Mus (genus Mus). Genetics (1989) 1.11
Shear vs pressure as causative factors in skin blood flow occlusion. Arch Phys Med Rehabil (1979) 1.10
A repeated segment on the mouse Y chromosome is composed of retroviral-related, Y-enriched and Y-specific sequences. Genetics (1989) 1.08
Incorporation of L-methionine-methyl-14C into gentamicins. II. Large-scale preparation of methyl-14C-gentamicins. J Antibiot (Tokyo) (1974) 1.08
Occupational lead exposure of storage battery workers in Korea. Br J Ind Med (1982) 1.08
Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol (1991) 1.08
Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populations. Am Heart J (1997) 1.08
Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J (1995) 1.07
Mouse mammary tumor virus polypeptide precursors in intracytoplasmic A particles. J Natl Cancer Inst (1975) 1.07
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up. Breast Cancer Res Treat (2008) 1.07
delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med (1997) 1.05
Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation (1988) 1.04
Risk of asbestosis in crocidolite and amosite mines in South Africa. Ann N Y Acad Sci (1979) 1.04
Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. J Clin Invest (1974) 1.03
Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care (1995) 1.03
Exercise testing to predict outcome in patients with angina. J Gen Intern Med (1999) 1.00
Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells. J Antibiot (Tokyo) (1978) 0.99
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group. Am J Cardiol (1991) 0.98
Regression analysis of multiple protein structures. J Comput Biol (1998) 0.98
Restenosis or occlusion after carotid endarterectomy: a survey with ocular pneumoplethysmography. Arch Surg (1979) 0.98
Kijanimicin (Sch 25663), a novel antibiotic produced by Actinomadura kijaniata SCC 1256. Fermentation, isolation, characterization and biological properties. J Antibiot (Tokyo) (1981) 0.98
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach. Proc Natl Acad Sci U S A (2002) 0.97
Dietary intake of cadmium and lead among the general population in Korea. Environ Res (1995) 0.97
Mechanism of effect of nicotine on renal water excretion. Am J Physiol (1974) 0.96
Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens (1991) 0.96
Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. Kidney Int (1976) 0.96
Bioenergetic consequences of left ventricular remodeling. Circulation (1995) 0.95
Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med (2000) 0.94